Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
The addition of blinatumomab after induction chemotherapy in children with standard-risk disease of average or high risk of relapse significantly improved disease-free survival.
The New...
Pleural Plaques from Secondhand Asbestos Exposure
An 80-year-old woman had pleural plaques seen on chest radiographs. As a child, she had played with her father after he returned home from...
Teclistamab as Successful Treatment of Relapsed TEMPI Syndrome
A woman with TEMPI syndrome who had a second relapse after many years of disease control with myeloma-type therapy had a rapid response to...
Autopsy of a Drug Withdrawal — The Case of Melphalan Flufenamide
A December 2022 law introduced a new expedited withdrawal process for accelerated approvals. The first approval withdrawn with this pathway was that of melphalan...
